Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/13/12 → 12/23/15 |
Funding
- Covance: $468,910.69
TaiGen: Phase II, Open-Label Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination with G-CSF in Patients with Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease
- Schuster, Michael (PI)
- Gabig, Theodore (CoPI)
- Lan, Fengshuo (CoPI)
- Kiner-Strachan, Bonnie (CoPI)
- Richard, Shambavi (CoPI)
Project: Research